Australia Health News API

{
    "totalArticles": 196278,
    "articles": [
        {
            "id": "743c06f4e5c4a65bc170e1bfbf5aae7f",
            "title": "Scientist Richard Scolyer dies after cancer battle",
            "description": "World-renowned melanoma pathologist and former Australian of the Year Richard Scolyer has died from brain cancer aged 59.",
            "content": "Richard Scolyer was diagnosed with an incurable and aggressive stage four brain cancer in June 2023. Photo: Supplied:\nWorld-renowned melanoma pathologist Richard Scolyer has died following a lengthy public battle with brain cancer, after saying he wo... [5423 chars]",
            "url": "https://www.canberratimes.com.au/story/9287653/scientist-richard-scolyer-dies-after-cancer-battle/",
            "image": "https://www.canberratimes.com.au/images/transform/v1/crop/frm/silverstone-feed-data/b48ecf48-7351-45df-a6a6-1e464bf2c634.jpg/r0_90_800_510_w1200_h630_fmax.jpg",
            "publishedAt": "2026-06-07T21:29:28Z",
            "lang": "en",
            "source": {
                "id": "a6f65972b4a593b55dffbc2b25866ab5",
                "name": "The Canberra Times",
                "url": "https://www.canberratimes.com.au"
            }
        },
        {
            "id": "5ec64ac5ec745ee4755c41d45e498631",
            "title": "Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59",
            "description": "Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023",
            "content": "Prof Richard Scolyer, the world-renowned cancer researcher and former Australian of the Year, has died at the age of 59.\nScolyer’s family shared a statement the eminent pathologist and melanoma expert penned before his final stages of illness.\n“My fi... [3277 chars]",
            "url": "https://www.theguardian.com/australia-news/2026/jun/08/richard-scolyer-cancer-researcher-and-former-australian-of-the-year-dies-aged-59",
            "image": "https://i.guim.co.uk/img/media/a2fb30a9d7ff03318c25fff5c945019ca2a2bc51/290_0_6675_5340/master/6675.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&precrop=40:21,offset-x50,offset-y0&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=c340cdea55fd895b44c37da35844324f",
            "publishedAt": "2026-06-07T20:35:00Z",
            "lang": "en",
            "source": {
                "id": "558a003a7a0164e924408edec7e99f99",
                "name": "The Guardian",
                "url": "https://www.theguardian.com"
            }
        },
        {
            "id": "ec0b294733c95c2807dab9b063dff121",
            "title": "Orforglipron Boosts Insulin Glargine for Type 2 Diabetes",
            "description": "About The Study: In participants with type 2 diabetes inadequately controlled by insulin glargine, addition of oral orforglipron significantly",
            "content": "Why?\nWell, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don't put up a paywall – we believe in free access to information of public interest.\nMedia ownership in Australia is one of the most concentrat... [1010 chars]",
            "url": "https://www.miragenews.com/orforglipron-boosts-insulin-glargine-for-type-2-1687799/",
            "image": "https://cdn1.miragenews.com/tmp_cache?cdn=images.unsplash.com%2Fphoto-1517245386807-bb43f82c33c4%3Fixlib%3Drb-4.0.3%26amp%3Bixid%3DMnwxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8%26amp%3Bauto%3Dformat%26amp%3Bfit%3Dcrop%26amp%3Bw%3D1170%26amp%3Bq%3D80",
            "publishedAt": "2026-06-07T20:26:00Z",
            "lang": "en",
            "source": {
                "id": "0368281c39ba31f7435685e8b620f675",
                "name": "Mirage News",
                "url": "https://www.miragenews.com"
            }
        }
    ]
}